• 1. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 2. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 3. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 4. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 5. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210

• Catalysts and Inorganic Chemicals Inorganic Compounds Homogeneous non-metal compounds Homogeneous other non-metal compounds

Introduction to 2-(1,2-oxazol-3-yl)acetonitrile (CAS No. 55242-83-6)

2-(1,2-oxazol-3-yl)acetonitrile, identified by the Chemical Abstracts Service Number (CAS No.) 55242-83-6, is a significant organic compound that has garnered considerable attention in the field of pharmaceutical and chemical research. This heterocyclic nitrile derivative features a unique structural framework comprising an oxazole ring fused with an acetonitrile moiety, which endows it with distinct chemical properties and potential biological activities. The oxazole ring, a five-membered aromatic heterocycle containing one oxygen and one nitrogen atom, is well-documented for its role in medicinal chemistry due to its stability and ability to engage in hydrogen bonding interactions. The presence of the acetonitrile group further enhances its reactivity, making it a valuable intermediate in synthetic chemistry.

The compound’s molecular structure, characterized by a high degree of functional diversity, positions it as a versatile building block for the development of novel therapeutic agents. In recent years, there has been a growing interest in exploring the pharmacological potential of oxazole derivatives, particularly those incorporating nitrogen-containing functional groups such as nitriles. These modifications are often employed to improve metabolic stability, enhance binding affinity to biological targets, and modulate pharmacokinetic profiles. The specific combination of an oxazole ring and an acetonitrile substituent in 2-(1,2-oxazol-3-yl)acetonitrile suggests that it may exhibit properties conducive to drug discovery, such as bioavailability and target specificity.

Current research in medicinal chemistry increasingly emphasizes the importance of scaffold hopping—designing molecules with novel structural motifs—to overcome resistance mechanisms and identify new therapeutic opportunities. 2-(1,2-oxazol-3-yl)acetonitrile fits well within this paradigm, offering a scaffold that can be readily modified to explore diverse biological functions. For instance, studies have demonstrated that oxazole derivatives can serve as effective scaffolds for antimicrobial and anti-inflammatory agents. The nitrile group in 2-(1,2-oxazol-3-yl)acetonitrile further expands its utility, as nitriles are known to participate in various biochemical pathways and can be transformed into other functional groups through standard chemical transformations.

Recent advancements in computational chemistry have facilitated the rapid screening of virtual libraries containing compounds like 2-(1,2-oxazol-3-yl)acetonitrile, enabling researchers to predict potential biological activities with greater accuracy. Molecular docking studies have shown that this compound may interact with enzymes and receptors involved in critical disease pathways. For example, preliminary simulations suggest that it could bind to targets associated with neurological disorders or cancer metabolism. Such findings underscore the importance of exploring structurally unique compounds like 55242-83-6 for drug development.

The synthesis of 2-(1,2-oxazol-3-yl)acetonitrile involves well-established organic chemistry techniques, including condensation reactions and cyclization processes. The oxazole ring is typically constructed via the Hantzsch pyridine synthesis or via cyclization of β-keto esters or β-diketones with hydroxylamine derivatives. The introduction of the acetonitrile group can be achieved through nucleophilic substitution or metal-catalyzed coupling reactions. These synthetic strategies highlight the compound’s accessibility for further derivatization, allowing chemists to tailor its properties for specific applications.

In industrial applications, 55242-83-6 may serve as a precursor for more complex molecules used in agrochemicals or specialty chemicals. Its structural features make it amenable to further functionalization, enabling the production of compounds with tailored physicochemical properties such as solubility or lipophilicity. Additionally, the compound’s stability under various reaction conditions makes it a reliable intermediate in multi-step synthetic routes.

The growing body of literature on oxazole derivatives underscores their significance in modern drug discovery. Researchers are increasingly leveraging these heterocycles to develop treatments for infectious diseases, chronic conditions, and even neurodegenerative disorders. The incorporation of nitrogen-rich functional groups like nitriles enhances their pharmaceutical relevance by improving interactions with biological macromolecules. As such, compounds like 2-(1,2-oxazol-3-yl)acetonitrile represent promising candidates for further investigation.

Future directions in research may focus on optimizing synthetic routes to improve yield and scalability while exploring novel derivatives of this scaffold. Advances in green chemistry principles could also influence how this compound is produced and utilized, emphasizing sustainable methodologies that minimize waste and energy consumption. Collaborative efforts between academic institutions and pharmaceutical companies will be crucial in translating laboratory findings into tangible therapeutic advancements.

In conclusion, 55242-83-6 represents a structurally intriguing compound with significant potential in pharmaceutical research. Its unique combination of an oxazole ring and an acetonitrile group positions it as a valuable intermediate for drug discovery efforts aimed at addressing unmet medical needs. As our understanding of molecular interactions continues to evolve, 2-(1,2-ofoxazol -3 -yI)acetontrIle is poised to play an important role in shaping the next generation of therapeutic agents.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)